HBV Immunology | Room 715

Saturday, June 16, 2018
2:00 PM to 3:45 PM

Chairs: Barbara Rehermann & Patrick Kennedy

Invited Presentations:

2:00pm
Monocyte and DC function in chronic HBV and their role in immunomodulatory therapy
Adam Gehring, Toronto Centre for Liver Disease, Toronto

2:25pm
HBV-specific T cell immunity vs. virological control in chronic HBV infection
Georg Lauer, Massachusetts General Hospital/ Harvard Medical School, Boston

2:50pm
Immunological response to Stopping Nucleoside Analogues in Chronic HBV
Markus Cornberg, Medizinische Hochschule Hannover, Hannover

Oral Abstracts:

3:15pm
A decisive role of target cells during antiviral immunity in the liver
Annika Schneider, Institute Of Molecular Immunology & Experimental Oncology, München

3:30pm
Early function modulation and reprogramming of liver resident and infiltrating macrophages promote the establishment of HBV infection
Suzanne Faure-Dupuy, Cancer Research Center Of Lyon, Lyon

Return to Schedule